[Essential circulatory hyperkinesis and tobanum].
D000293:Adolescent; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D006801:Humans; D009449:Neurocirculatory Asthenia / Q000188:drug therapy*; D011412:Propanolamines / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; C025725:tobanum
Az esszenciális keringési hiperkinezis és a Tobanum.